American Healthcare REIT, Inc. (AHR) Stock Analysis

Q: What is the AHR stock price target?

Take-profit $50.22 (-0.7% upside). Prior stop was $47.61.

Q: What are the risks of investing in AHR?

REIT tenant concentration cliff: 56% of NOI from Trilogy Management Services (ISHC operator) (≥40% threshold). Single-tenant churn risk dominates spot FFO.; Concentration risk — Tenant: Trilogy Management Services (ISHC operator) (55.5%); Target reached (-0.3% upside); Target reached (-0.3% upside); Quality below floor (3.7 < 4.0).

Q: Is AHR overvalued or undervalued?

American Healthcare REIT, Inc. trades at a P/E of 119.5 (forward 51.4). TrendMatrix value score: 3.8/10. Overall verdict: Sell.

Q: What do analysts say about AHR?

10 analysts cover AHR with a consensus score of 4.0/5. Average price target: $58.

Breakout setup

SellModerate ConfidenceUpdated 2026-04-30

Real Estate · REIT - Healthcare Facilities

Earnings in 7 days (2026-05-07). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Engine safety override at $50.57: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.5/10. Specifically: Below-average business quality; Rich valuation.

American Healthcare REIT is a self-managed healthcare REIT owning senior housing (ISHC/SHOP), skilled nursing facilities, and outpatient medical buildings in the U.S., UK, and Isle of Man. Its integrated senior health campuses, all managed by Trilogy Management Services,... Read more

$50.57-0.7% A.UpsideScore 5.5/10#5 of 13 REIT - Healthcare Facilities

Stop $47.61Target $50.22(resistance)A.R:R -0.1:1

Analyst target$57.92+14.5%13 analysts

$50.22our TP

$50.57price

$57.92mean

$63

Passes 5/8 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 7d<=7d and reit tenant cliff hard block. Suitability: moderate.

Thesis

Rewards

No bull case signals

Risks

REIT tenant concentration cliff: 56% of NOI from Trilogy Management Services (ISHC operator) (≥40% threshold). Single-tenant churn risk dominates spot FFO.

Concentration risk — Tenant: Trilogy Management Services (ISHC operator) (55.5%)

Target reached (-0.3% upside)

Key Metrics

P/E (TTM)119.5

P/E (Fwd)51.4

Mkt Cap$9.6B

EV/EBITDA28.5

Profit Mgn3.1%

ROE2.5%

Rev Growth11.9%

Beta1.18

Dividend1.99%

Rating analysts10

Quality Signals

Piotroski F7/9

Options Flow

IV52%elevated

Concentration Risks(10-K Item 1A)

HIGHTenantTrilogy Management Services (ISHC operator)56%
10-K Item 1A: 'All of our ISHC are managed by the Trilogy Manager... contributed approximately 55.5% of our annualized base rent/annualized net operating income, or NOI, as of such date.'

Material Events(8-K, last 90d)

2026-02-04Item 5.02HIGH
CEO Danny Prosky on medical leave effective February 3, 2026. Former CEO Jeffrey T. Hanson appointed Interim CEO and President. No permanent successor named; Prosky return date unknown.
SEC filing →
2026-03-24Item 5.02LOW
Employment letter for Interim CEO Jeffrey Hanson formalized with retroactive effect from February 4, 2026. Base salary $70,666/month; 120% annual bonus target. Compensation arrangement for existing Interim CEO appointment.
SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

2 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value3.815%0.57

Quality3.715%0.56

Growth7.815%1.17

Momentum6.910%0.69

Sentiment6.610%0.66

Insider Activity5.010%0.50

Peer Rank4.610%0.46

Technical Setup4.15%0.20

Risk Profile6.05%0.30

Catalyst8.05%0.40

Overall (Σ contributions)5.51

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin

0.0

Roe

0.8

Roa

1.4

Net Margin

1.5

Operating Margin

2.7

Current Ratio

3.8

Moat

5.0

Piotroski F

7.8

Fcf Quality

10.0

Excellent cash conversion: 489% FCF/NINo competitive moatStrong Piotroski F-Score: 7/9

Priced at a premium — multiples above sector norms. Needs delivery on growth + margins to justify.static

Ev Ebitda

0.0

P Ocf

3.4

Analyst Target

4.0

7.4

P/OCF: 32.7x (FFO proxy — REITs gated off P/E)

GatesA.R:R -0.1=NEGATIVEEARNINGS PROXIMITY 7d<=7dREIT TENANT CLIFF HARD BLOCKMomentum 6.9>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTSEMI CYCLE PEAK CLEARBreakoutSuitability: Moderate

RSI

56 · Neutral

↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $46.85Resistance $51.24

Price Targets

$48

$50

A.Upside-0.7%

A.R:R-0.1:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Target reached (-0.3% upside)

! Quality below floor (3.7 < 4.0)

! Negative risk/reward — downside exceeds upside

Earnings

3/4 beats

Next Earnings2026-05-07 (7d)

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is AHR stock a buy right now?

Sell if holding. Engine safety override at $50.57: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.5/10. Specifically: Below-average business quality; Rich valuation. Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Prior stop was $47.61. Score 5.5/10, moderate confidence.

What is the AHR stock price target?

Take-profit target: $50.22 (-0.7% upside). Prior stop was $47.61. Stop-loss: $47.61.

What are the risks of investing in AHR?

REIT tenant concentration cliff: 56% of NOI from Trilogy Management Services (ISHC operator) (≥40% threshold). Single-tenant churn risk dominates spot FFO.; Concentration risk — Tenant: Trilogy Management Services (ISHC operator) (55.5%); Target reached (-0.3% upside).

Is AHR overvalued or undervalued?

American Healthcare REIT, Inc. trades at a P/E of 119.5 (forward 51.4). TrendMatrix value score: 3.8/10. Verdict: Sell.

What do analysts say about AHR?

10 analysts cover AHR with a consensus score of 4.0/5. Average price target: $58.

What does American Healthcare REIT, Inc. do?American Healthcare REIT is a self-managed healthcare REIT owning senior housing (ISHC/SHOP), skilled nursing...